Implication of protocadherin-PC in the progression of the advanced prostate cancer
Saved in:
| Published in: | Experimental Oncology |
|---|---|
| Date: | 2007 |
| Main Authors: | Giannakopoulos, X., Stagikas, D., Peschos, D., Batistatou, A., Charalabopoulos, K. |
| Format: | Article |
| Language: | English |
| Published: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2007
|
| Subjects: | |
| Online Access: | https://nasplib.isofts.kiev.ua/handle/123456789/138559 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Cite this: | Implication of protocadherin-PC in the progression of the advanced prostate cancer / X. Giannakopoulos, D. Stagikas, D. Peschos, A. Batistatou, K. Charalabopoulos // Experimental Oncology. — 2007. — Т. 29, № 1. — С. 74-75. — Бібліогр.: 8 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineSimilar Items
Paraganglioma-like dermal melanocytic tumor: a rare skin lesion
by: Zinovkin, D.A., et al.
Published: (2015)
by: Zinovkin, D.A., et al.
Published: (2015)
Rethinking anticancer screening strategies saving lives at front line. Results from SESy_Europe task force
by: Mauri, D., et al.
Published: (2006)
by: Mauri, D., et al.
Published: (2006)
Vitamin C: attenuating effect on growth and proliferation in systemic malignancies
by: Kapoor, S.
Published: (2013)
by: Kapoor, S.
Published: (2013)
Anagrelide and the CALR mutation allele burden in essential thrombocythemia
by: Atkinson, E., et al.
Published: (2018)
by: Atkinson, E., et al.
Published: (2018)
The second Ukrainian-Swedish workshop "Translational oncology: old and new paradigms”
Published: (2013)
Published: (2013)
Ukrain and its emerging role as an antineoplastic agent in systemic malignancies
by: Kapoor S.
Published: (2013)
by: Kapoor S.
Published: (2013)
Amplification and co-regulators of androgen receptor gene in prostate cancer
by: Golias, Ch., et al.
Published: (2009)
by: Golias, Ch., et al.
Published: (2009)
The role of intercellular adhesion molecule-1 in head and neck cancer
by: Georgolios, A., et al.
Published: (2006)
by: Georgolios, A., et al.
Published: (2006)
Clinical implications of p53 alterations in oral cancer progression: a review from India
by: Patel, K.R., et al.
Published: (2018)
by: Patel, K.R., et al.
Published: (2018)
The function of poliamine metabolism in prostate cancer
by: Palavan-Unsal, N., et al.
Published: (2006)
by: Palavan-Unsal, N., et al.
Published: (2006)
Expression of cancer-associated genes in prostate tumors
by: Rosenberg, E.E., et al.
Published: (2017)
by: Rosenberg, E.E., et al.
Published: (2017)
Gene expression of polyamine metabolism proteins in human prostate cancer and benign prostatic hyperplasia
by: V. V. Bentrad, et al.
Published: (2020)
by: V. V. Bentrad, et al.
Published: (2020)
Precision therapy to target apoptosis in prostate cancer
by: Kulik, G.
Published: (2014)
by: Kulik, G.
Published: (2014)
NANOG as prognostic factor of prostate cancer course
by: Zadvornyi, T.V., et al.
Published: (2023)
by: Zadvornyi, T.V., et al.
Published: (2023)
Morpholoogical features of castratoin-resistent prostate cancer
by: L. H. Rosha, et al.
Published: (2018)
by: L. H. Rosha, et al.
Published: (2018)
Precision therapy to target apoptosis in prostate cancer
by: G. Kulik
Published: (2014)
by: G. Kulik
Published: (2014)
The effect of metabolic syndrome on prostatic cancer development
by: T. A. Nalbandjan
Published: (2016)
by: T. A. Nalbandjan
Published: (2016)
Crossing chromosomes in pleomorphic sarcoma
by: Batistatou, A., et al.
Published: (2006)
by: Batistatou, A., et al.
Published: (2006)
Non-standard case of cancer of prostate gland (clinical case)
by: O. M. Zacheslavskyi, et al.
Published: (2018)
by: O. M. Zacheslavskyi, et al.
Published: (2018)
Survival rates of familial and sporadic prostate cancer patients
by: Plonis, J., et al.
Published: (2015)
by: Plonis, J., et al.
Published: (2015)
Profiling of metabolic biomarkers in the serum of prostate cancer patients
by: F. Ali, et al.
Published: (2020)
by: F. Ali, et al.
Published: (2020)
Survival rates of familial and sporadic prostate cancer patients
by: J. Plonis, et al.
Published: (2015)
by: J. Plonis, et al.
Published: (2015)
Development of gene expression panels to determine prostate cancer
by: G. V. Gerashchenko, et al.
Published: (2019)
by: G. V. Gerashchenko, et al.
Published: (2019)
Minimal non-\(PC\)-groups
by: Artemovych, Orest D.
Published: (2018)
by: Artemovych, Orest D.
Published: (2018)
Minimal non-PC-groups
by: Artemovych, O.D.
Published: (2014)
by: Artemovych, O.D.
Published: (2014)
Minimal non-PC-groups
by: O. D. Artemovych
Published: (2014)
by: O. D. Artemovych
Published: (2014)
Modern algorithm of treatment of patients with prostate cancer with bone metastases
by: O. V. Ponomareva, et al.
Published: (2017)
by: O. V. Ponomareva, et al.
Published: (2017)
Expression pattern of genes associated with tumor microenvironment in prostate cancer
by: Gerashchenko, G.V., et al.
Published: (2018)
by: Gerashchenko, G.V., et al.
Published: (2018)
Impact of metabolic syndrome on development of castration-resistant prostate cancer
by: Ju. A. Vinnik, et al.
Published: (2017)
by: Ju. A. Vinnik, et al.
Published: (2017)
Blood and urine polyamine as new diagnostic markers of prostate cancer
by: S. P. Zalietok, et al.
Published: (2019)
by: S. P. Zalietok, et al.
Published: (2019)
Effect of trichostatin a on viability and microRNA expression in human pancreatic cancer cell line BxPC-3
by: Zhang, S., et al.
Published: (2008)
by: Zhang, S., et al.
Published: (2008)
Dynamics of prostate cancer rate and mortality in Ukraine: current state of aff airs
by: Yu. Kobilnyk, et al.
Published: (2020)
by: Yu. Kobilnyk, et al.
Published: (2020)
Health-dependent quality of life in patients with disseminated hormone-naive prostate cancer
by: V. N. Lesovoj, et al.
Published: (2016)
by: V. N. Lesovoj, et al.
Published: (2016)
Biochemical and cytogenetic indices of peripheral blood lymphocytes in patients with prostate cancer
by: E. A. Domina, et al.
Published: (2018)
by: E. A. Domina, et al.
Published: (2018)
Search for genes – potential markers of aggressiveness and metastasis for human prostate cancer
by: E. E. Rozenberh, et al.
Published: (2013)
by: E. E. Rozenberh, et al.
Published: (2013)
Effect of androgen suppression on bone mineral density in patients with prostate cancer
by: O. A. Chernichenko, et al.
Published: (2014)
by: O. A. Chernichenko, et al.
Published: (2014)
Assessment of gold nanoparticle effect on prostate cancer LNCaP cells
by: A. G. Reznikov, et al.
Published: (2015)
by: A. G. Reznikov, et al.
Published: (2015)
Effect of androgen suppression on bone mineral density in patients with prostate cancer
by: Chernichenko, O.A., et al.
Published: (2014)
by: Chernichenko, O.A., et al.
Published: (2014)
Assessment of gold nanoparticle effect on prostate cancer LNCaP cells
by: Reznikov, A.G., et al.
Published: (2015)
by: Reznikov, A.G., et al.
Published: (2015)
Targeted modulation of integrin expression increases freeze sensitivity of androgen-insensitive prostate cancer
by: J. M. Baust, et al.
Published: (2010)
by: J. M. Baust, et al.
Published: (2010)
Similar Items
-
Paraganglioma-like dermal melanocytic tumor: a rare skin lesion
by: Zinovkin, D.A., et al.
Published: (2015) -
Rethinking anticancer screening strategies saving lives at front line. Results from SESy_Europe task force
by: Mauri, D., et al.
Published: (2006) -
Vitamin C: attenuating effect on growth and proliferation in systemic malignancies
by: Kapoor, S.
Published: (2013) -
Anagrelide and the CALR mutation allele burden in essential thrombocythemia
by: Atkinson, E., et al.
Published: (2018) -
The second Ukrainian-Swedish workshop "Translational oncology: old and new paradigms”
Published: (2013)